Aging Services
ECRI's Top 10 Health Technology Hazards: A Vital Resource for Healthcare Providers
We're excited to announce that ECRI's highly anticipated annual report—Top 10 Health Technology Hazards for 2025—is on the way and is launching early! This report is crucial for healthcare organiza...
Read moreBalancing Disinfection and Manufacturer Recommendations in Ultrasound Technologies
Introduction As the use of ultrasound technology continues to expand across various medical disciplines—from radiology and cardiology to point-of-care applications—ensuring appropriate and effectiv...
Read moreFive Key Takeaways on Video-Based Patient Monitoring for Preventing Falls
ECRI named ongoing challenges related to patient falls as one of its 2024 Top 10 Patient Safety Concerns because falls continue to be the number one sentinel event reported to the Joint Commission ...
Read moreNavigating the Evolving Landscape in Healthcare Value Analysis: Strategies for Success
The role of Value Analysis in Healthcare is pivotal as the industry faces constant change and transformation. Due to the nature of this complex specialty, it is necessary to illustrate and define a...
Read moreUsing Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs
Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight loss—Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—could potentially make much needed g...
Read moreMonitoring Patients Who Take GLP-1 RAs for Weight Loss – What Prescribers Should Know
Roughly one year after their introduction, Wegovy (semaglutide) and Zepbound (tirzepatide) continue to shake up the obesity treatment landscape in the United States. Uptake for these two glucagon-l...
Read moreWeighing the Evidence on New Weight Loss Drugs – Five Takeaways
The prevalence of overweight and obesity keeps worsening in America despite our enormous collective effort to lose weight. The U.S. Centers for Disease Control and Prevention estimates that overwei...
Read moreIn the last two decades, the number of commercially available genetic tests is thought to have increased by more than 5,000%—from approximately 1,500 to an estimated 100,000 or more. This number on...
Read moreIncreased Payer Support for Telemedicine May Improve Maternal Health Outcomes and Lower Costs
When compared to ten other developed nations, the United States has the highest maternal death rate. Yet, according to a recent maternal mortality review committee report by the Centers for Disease...
Read more